Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization

Journal of Urology

Volumn 167, Issue 6, 2002, Pages 2521-2522

  Master, Viraj A ^a   Meng, Maxwell V ^a   Koppie, Theresa M ^a   Carroll, Peter R ^a   Grossfeld, Gary D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bladder neoplasms; Carcinoma, transitional cell; Immunosuppression; In situ hybridization, fluorescence; Transplantation

Indexed keywords

CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LAPAROTOMY; LYMPHADENOPATHY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINARY DIVERSION; UROGENITAL TRACT CANCER; X CHROMOSOME;

EID: 0036096005     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65021-5     Document Type: Article

References (3)

1. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics
2. Identification of the origin of a vesical mass occurring after cadaveric renal transplantation using short tandem repeat markers
3. Fluorescence in situ hybridization (FISH) for rapid detection of aneuploidy: Experience in 911 prenatal cases